Publications scientifiques en Dermatologie

INTERVENTIONS SCIENTIFIQUES

Dr Natalia Kirsten

Depuis plusieurs années, le Dr Natalia Kirsten mène des recherches scientifiques poussées sur les maladies inflammatoires de la peau à l’hôpital universitaire de Hambourg, où elle est également chef de clinique. Très active dans la transmission des connaissances, elle intervient régulièrement lors de congrès internationaux et forme de nombreux dermatologues et étudiants.

Kirsten N, Mohr N, Augustin M. Prevalence and Cutaneous Comorbidity of Acne Vulgaris in the Working Population. Clin Cosmet Investig Dermatol. 2021 Oct 2;14:1393-1400. doi: 10.2147/CCID.S322876. eCollection 2021.

Kirsten N, Rustenbach S, von Kiedrowski R, Sorbe C, Reich K, Augustin M. Which PASI Outcome Is Most Relevant to the Patients in Real-World Care? Life (Basel). 2021 Oct 28;11(11):1151. doi: 10.3390/life11111151.

Kirsten N, Mohr N, Gensel F, Alhumam A, Bruning G, Augustin M. Population-Based Epidemiologic Study in Venous Diseases in Germany – Prevalence, Comorbidity, and Medical Needs in a Cohort of 19,104 Workers. Vasc Health Risk Manag. 2021 Oct 29;17:679-687. doi: 10.2147/VHRM.S323084. eCollection 2021.

Maximilian R, Garbe C, Petersen J, Augustin M, Kirsten N, Biermann MHC, Häberle BM, Hagenström K. Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis. Acta Derm Venereol. 2021 Oct 11;101(10):adv00566. doi: 10.2340/00015555-3879.

Kirsten N, Mohr N, Alhumam A, Augustin M. Prevalence and Associated Diseases of Seborrheic Skin in Adults. Clin Epidemiol. 2021 Sep 18;13:845-851. doi: 10.2147/CLEP.S323744. eCollection 2021.

Kirsten N, Frings V, Nikolakis GD, Presser D, Goebeler M, Zouboulis CC, Augustin M. [Epidemiology, patient quality of life, and treatment costs of hidradenitis suppurativa/acne inversa].

Hautarzt. 2021 Aug;72(8):651-657. doi: 10.1007/s00105-021-04851-z. Epub 2021 Jul 5.

Kirsten N, Gensel F, Augustin M. Kaltplasma-Therapie bei Pyoderma gangrenosum. J Dtsch Dermatol Ges. 2021 Jul;19 Suppl 1:17-19. doi: 10.1111/ddg.14474.

Augustin M, Garbe C, Girbig G, Strömer K, Kirsten N. [Epidemiology of scabies in Germany: multisource analysis of primary and secondary data]. Hautarzt. 2022 Jan;73(1):61-66. doi: 10.1007/s00105-021-04895-1. Epub 2021 Oct 4.

Reinders P, Otten M, Augustin M, Stephan B, Kirsten N. [Areas of application for teledermatology]. Hautarzt. 2022 Jan;73(1):47-52. doi: 10.1007/s00105-021-04917-y. Epub 2021 Nov 5.

Augustin M, Djamei V, Elsner P, Gass S, Hofmann-Wellenhof R, Kaminski K, Kirsten N, Nast A, Navarini-Meury A, Otten M, Salzer B, von Kiedrowski R, Zink A, Strömer K.J  S2k-Guideline for Teledermatology. Dtsch Dermatol Ges. 2021 Dec 21. doi: 10.1111/ddg.14615. Online ahead of print.

Hilbring C, Augustin M, Kirsten N, Mohr N. Epidemiology of rosacea in a population-based study of 161,269 German employees. Int J Dermatol. 2021 Dec 12. doi: 10.1111/ijd.15989. Online ahead of print.

Langenbruch A, Mohr N, Kirsten N, Reich K, von Kiedrowski R, Strömer K, Mrowietz U, Augustin M. Quality of psoriasis care in Germany – results from the nationwide health care studies PsoHealth 2004-2017. J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1536-1542. doi: 10.1111/jdv.17220. Epub 2021 May 7.

Klein TM, Andrees V, Kirsten N, Protz K, Augustin M, Blome C. Social participation of people with chronic wounds: A systematic review. Int Wound J. 2021 Jun;18(3):287-311. doi: 10.1111/iwj.13533. Epub 2020 Dec 13.

Zyriax BC, Augustin M, Abeck F, Mohr N, Kirsten N, Langenbruch A. Adherence to Guideline-Oriented Preventive Measures in Patients with Atopic Dermatitis in Germany. Dermatology. 2021 Jun 25:1-6. doi: 10.1159/000517019. Online ahead of print.

Mohr N, Petersen J, Kirsten N, Augustin M. Epidemiology of Vitiligo – A Dual Population-Based Approach. Clin Epidemiol. 2021 May 26;13:373-382. doi: 10.2147/CLEP.S304155. eCollection 2021.

Kirsten N, Zander N, Augustin M. Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population. Arch Dermatol Res. 2021 Mar;313(2):95-99. doi: 10.1007/s00403-020-02065-2. Epub 2020 Apr 22.

Kirsten N, Mohr N, Maul JT, Augustin M. Incidence of atopic conditions in people with psoriasis: a population-based analysis. Eur J Dermatol. 2021 Feb 1;31(1):60-64. doi: 10.1684/ejd.2021.3963.

Zander N, Naatz M, Augustin M, Langenbruch A, Topp J, Mrowietz U, von Kiedrowski R, Krensel M, Jungen D, Kirsten N. Determinants of costs and benefits in psoriasis routine care: results from a cross-sectional nationwide study in Germany. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e63-e65. doi: 10.1111/jdv.16807. Epub 2020 Aug 3.

Klein TM, Augustin M, Kirsten N, Otten M. Attitudes towards using electronic health records of patients with psoriasis and dermatologists: a cross-sectional study. BMC Med Inform Decis Mak. 2020 Dec 30;20(1):344. doi: 10.1186/s12911-020-01302-y.

Blome C, Kirsten N, Nergiz I, Schiffner U, Otten M, Augustin M. New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany.BMJ Open. 2020 Dec 1;10(12):e039227. doi: 10.1136/bmjopen-2020-039227.

da Silva N, Augustin M, Langenbruch A, Mrowietz U, Reich K, Thaçi D, Boehncke WH, Kirsten N, Danckworth A, Sommer R. Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care. PLoS One. 2020 Jul 1;15(7):e0235091. doi: 10.1371/journal.pone.0235091. eCollection 2020.

da Silva N, Augustin M, Langenbruch A, Mrowietz U, Reich K, Thaçi D, Boehncke WH, Kirsten N, Danckworth A, Sommer R. Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care. Eur J Dermatol. 2020 Jun 1;30(3):267-278. doi: 10.1684/ejd.2020.3768.

Augustin M, Langenbruch A, Blome C, Gutknecht M, Werfel T, Ständer S, Steinke S, Kirsten N, Silva N, Sommer R. Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):142-152. doi: 10.1111/jdv.15919. Epub 2019 Nov 5.

Kirsten N, Petersen J, Hagenström K, Augustin M. Epidemiology of hidradenitis suppurativa in Germany – an observational cohort study based on a multisource approach. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):174-179. doi: 10.1111/jdv.15940. Epub 2019 Oct 8.

Augustin M, Sommer R, Kirsten N, Danckworth A, Radtke MA, Reich K, Thaci D, Boehncke WH, Langenbruch A, Mrowietz U. Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients. Br J Dermatol. 2019 Aug;181(2):358-365. doi: 10.1111/bjd.17403. Epub 2019 Jan 24.

Zander N, Sommer R, Schäfer I, Reinert R, Kirsten N, Zyriax BC, Maul JT, Augustin M. Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees. Br J Dermatol. 2019 Oct;181(4):743-748. doi: 10.1111/bjd.17826. Epub 2019 Jul 17.

Gasslitter I, Kirsten N, Augustin M, Torz K, Mrowietz U, Eyerich K, Puig L, Hoetzenecker W, Schütz-Bergmayr M, Weger W, Wolf P, Reider N, Ratzinger G, Papageorgiou K, Meier TO, Maul JT, Anzengruber F, Navarini AA. Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study. Arch Dermatol Res. 2019 Jul;311(5):421-424. doi: 10.1007/s00403-019-01907-y. Epub 2019 Mar 16.

Augustin M, Kirsten N, Körber A, Wilsmann-Theis D, Itschert G, Staubach-Renz P, Maul JT, Zander N. Prevalence, predictors and comorbidity of dry skin in the general population. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):147-150. doi: 10.1111/jdv.15157. Epub 2018 Jul 24.

Casassa EA, Mailhol C, Tournier E, Laurent C, Degboe Y, Eischen M, Kirsten N, Moreau J, Evrard SM, Mansat-De Mas V, Lamant L, Dubreuil P, Apoil PA, Hermine O, Paul C, Bulai Livideanu C. Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock. Allergol Int. 2019 Jan;68(1):119-121. doi: 10.1016/j.alit.2018.07.003. Epub 2018 Aug 7.

Kirsten N, Herberger K, Augustin M, Tigges W, Behrendt C, Heidemann F, Debus ES, Diener H. [Modern wound treatment-from best practice to innovation].Chirurg. 2018 Nov;89(11):931-942. doi: 10.1007/s00104-018-0731-1.

Kirsten N, Tournier E, Lepage B, Lamant L, Hermine O, Paul C, Bulai Livideanu C. Immunohistochemical staining for diagnosis of cutaneous mastocytosis. J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e160-e162. doi: 10.1111/jdv.13946. Epub 2016 Sep 12.

Kirsten N, Bulai Livideanu C, Richard MA, Konstantinou MP, Khemis A, Balluteaud C, Goujon C, Beylot-Barry M, Paul C; French Psoriasis Research Group. Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development. Br J Dermatol. 2016 Sep;175(3):636-8. doi: 10.1111/bjd.14622. Epub 2016 Jul 5.

Herberger K, Franzke N, Blome C, Kirsten N, Augustin M. Efficacy, tolerability and patient benefit of ultrasound-assisted wound treatment versus surgical debridement: a randomized clinical study.Dermatology. 2011;222(3):244-9. doi: 10.1159/000326116. Epub 2011 Apr 5.

VOTRE DERMATOLOGUE

À Propos du Dr Natalia Kirsten

Le Dr Natalia Kirsten, formée dans les prestigieuses universités de Hambourg et Toulouse, a développé une expertise pointue dans le domaine des affections cutanées complexes et des interventions esthétiques délicates. Sa formation internationale constitue un atout majeur, lui permettant d’élaborer des solutions sur mesure pour chacun de ses patients. Dans son cabinet empreint de sérénité, elle accueille sa clientèle avec bienveillance et attention, privilégiant une approche chaleureuse et individualisée des soins dermatologiques haut de gamme.